TSC2-deficient tumors have evidence of T cell exhaustion and respond to anti–PD-1/anti–CTLA-4 immunotherapy
Heng-Jia Liu(Brigham and Women's Hospital), Elizabeth P. Henske(Brigham and Women's Hospital)
Cited by 73
Related Papers
Folliculin, the Product of the Birt-Hogg-Dube Tumor Suppressor Gene, Interacts with the Adherens Junction Protein p0071 to Regulate Cell-Cell Adhesion
|PLoS ONE|2012|159
Renal Angiomyolipomas from Patients with Sporadic Lymphangiomyomatosis Contain Both Neoplastic and Non-Neoplastic Vascular Structures
|American Journal Of Pathology|2003|117
mTORC1 upregulates B7-H3/CD276 to inhibit antitumor T cells and drive tumor immune evasion
|Nature Communications|2023|111
TSC2 regulates lysosome biogenesis via a non-canonical RAGC and TFEB-dependent mechanism
|Nature Communications|2021|99
TFEB drives mTORC1 hyperactivation and kidney disease in Tuberous Sclerosis Complex
|Nature Communications|2024|43